LONDON, June 20, 2017 /PRNewswire/ -- Highlights
Advertisement
- The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc.
- Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential.
- Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.
- In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth.
- People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals.
- Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cancer-biomarker-market-is-expected-to-reach-a-value-of-usd-337-billion-by-2025-300477100.html
SOURCE ReportBuyer